A new National Institute for Health and Social Care (NIHR) Fellowship Project (NIHR503756).
Principal Investigator: Dr Paul Briley.
Transcranial magnetic stimulation (TMS) is a type of neuromodulation (non-invasive brain stimulation) treatment. It uses magnetic pulses to re-balance brain activity. A patient attends a clinic once a day Monday to Friday for several weeks to receive a short TMS treatment. TMS is performed whilst a person is awake and alert, they can chat to the TMS practitioner and go home straight after.
Transcranial magnetic stimulation (TMS) is one of the most effective treatments for depression.
However, not everyone benefits, and for many the long treatment courses, and need to attend clinic every day, make the treatment inaccessible. This has also contributed to poor availability of treatment on the NHS, despite TMS being recommended by NICE (HTG396) (the body that recommends treatments for use within the UK NHS) in 2015.
Over the next four years, the EnhanceTMS project will explore ways to boost response to TMS and improve treatment accessibility.
If you would be interested in finding out more about the EnhanceTMS study as it progresses, you can sign up to our mailing list
EnhanceTMS Mailing List